IL17A and rheumatoid arthritis: In addition, we also demonstrate that LLDT-8 would inhibit the nuclear translocation of the p65 (Fig. 5B) which is the significant effect of TNF and IL-17, indicating LLDT-8 has significant inhibition to TNF and IL-17 effects and therefore have potential pharmacological effect to RA therapy.